Biolinerx Ltd ADR (BLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 477 | 194 | 427 | 304 | 255 |
| Cost of Goods | 95 | 40 | 84 | 72 | 34 |
| Gross Profit | 382 | 154 | 343 | 232 | 221 |
| Operating Expenses | 3,481 | 3,580 | 2,634 | 2,607 | 2,646 |
| Operating Income | -3,004 | -3,386 | -2,207 | -2,303 | -2,391 |
| Interest Expense | 250 | 280 | 304 | 276 | 420 |
| Other Income | 666 | 1,430 | 1,534 | -1,361 | 7,938 |
| Pre-tax Income | -2,588 | -2,236 | -977 | -3,940 | 5,127 |
| Net Income Continuous | -2,588 | -2,236 | -977 | -3,940 | 5,127 |
| Minority Interests | -987 | N/A | N/A | N/A | N/A |
| Net Income | $-1,601 | $-1,385 | $-977 | $-3,940 | $5,127 |
| EPS Basic Continuous Ops | -0.58 | -0.66 | -0.22 | -1.00 | 1.39 |
| EPS Diluted Continuous Ops | -0.58 | -0.66 | -0.22 | -1.00 | 1.39 |
| EPS Diluted Before Non-Recurring Items | -0.36 | -0.34 | -0.22 | -1.00 | 1.39 |
| EBITDA(a) | $-2,916 | $-3,323 | $-2,088 | $-2,127 | $-2,226 |